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Abstract
Understanding the heterogeneous nature of dengue transmission is important for prioritizing
and guiding the implementation of prevention strategies. However, passive surveillance
data in endemic countries are rarely adequately informative. We analyzed data from a clus-
ter-sample, cross-sectional seroprevalence study in 1–18 year-olds to investigate geo-
graphic differences in dengue seroprevalence and force of infection in Indonesia. We used
catalytic models to estimate the force of infection in each of the 30 randomly selected sub-
districts. Based on these estimates, we determined the proportion of sub-districts expected
to reach seroprevalence levels of 50%, 70% and 90% by year of age. We used population
averaged generalized estimating equation models to investigate individual- and cluster-level
determinants of dengue seropositivity. Dengue force of infection varied substantially across
Indonesia, ranging from 4.3% to 30.0% between sub-districts. By age nine, 60% of sub-dis-
tricts are expected to have a seroprevalence�70%, rising to 83% by age 11. Higher odds of
seropositivity were associated with higher population density (OR = 1.54 per 10-fold rise in
population density, 95% CI: 1.03–2.32) and with City (relative to Regency) administrative
status (OR = 1.92, 95% CI: 1.32–2.79). Our findings highlight the substantial variation in
dengue endemicity within Indonesia and the importance of understanding spatial heteroge-
neity in dengue transmission intensity for optimal dengue prevention strategies including
future implementation of dengue vaccination programmes.
Author summary
Understanding the geographic distribution of dengue transmission intensity is of key
importance for guiding dengue prevention strategies, including vaccination. We analyzed
age-stratified data from a cross-sectional survey of 30 randomly selected urban sub-
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districts in Indonesia and estimated the force of infection (FOI) in each. Substantial varia-
tion in FOI estimates were observed, ranging from 4% to 30% between sub-districts. Het-
erogeneity which will be important to understand when considering future vaccine
introduction in Indonesia. Higher odds of dengue seropositivity were associated with
increasing levels of urbanization, which may represent areas where more people could
benefit from dengue vaccination or should otherwise be prioritized for dengue control.
Introduction
Dengue is the most widely distributed mosquito-borne viral infection; 40% of the world’s pop-
ulation is at risk, three-quarters of whom live in the Asia-Pacific region [1–3]. However, the
burden of dengue disease remains poorly quantified in many dengue endemic countries in
Asia because existing passive surveillance systems capture only a small fraction of all dengue
cases, often relying on clinical diagnoses which excludes milder and atypical presentations of
disease [4,5].
Indonesia is one of the largest countries in the dengue endemic region, with a population of
260 million, more than half of whom live in urban areas. Dengue transmission in Indonesia is
hyper-endemic, with co-circulation of all four dengue serotypes. In 2013, the Ministry of
Health of Indonesia reported 112,511 cases of dengue (41.3 per 100,000 population) and 871
deaths, corresponding to a case fatality rate of 0.7% [6]. Variable application of surveillance
case definitions, health-seeking behaviour and lack of laboratory confirmation means that the
rates of dengue infection and disease are likely to be heavily underestimated [7,8]. In a longitu-
dinal study of dengue burden in high-incidence populations within five Southeast Asian coun-
tries (Indonesia, Malaysia, Thailand, the Philippines and Vietnam), the rate of virologically-
confirmed dengue in healthy Indonesian children aged 2–14 years was 3.6 cases per 100 per-
son-years, more than 10 times that detected by national surveillance data. The sensitivity of
clinical diagnosis in this research environment in Indonesia was 59% [9,10]. Of the five coun-
tries, the Indonesian cohort experienced the highest rate of virologically-confirmed dengue
hospitalizations (1.6 hospitalizations per 100 person-years) and dengue haemorrhagic fever
(0.6 episodes per 100 person-years) [9].
Dengue transmission can exhibit significant temporal and geographical variability even at
small spatial scales, with large variations in dengue incidence sometimes observed in neigh-
bouring administrative units [11,12]. Drivers of such differences in dengue transmission may
be multifactorial, with climatic variables, level of urbanization, socioeconomic factors and vec-
tor ecology likely to be playing significant roles. Determining the roles of these factors in local
dengue transmission can help inform decisions about where prevention and control strategies
may be most needed.
In September 2016, Indonesia approved Dengvaxia (Sanofi Pasteur), a live-attenuated, chi-
meric, tetravalent dengue vaccine. The vaccine is recommended for use in individuals who
have already experienced dengue infection [13]. The World Health Organization (WHO) Stra-
tegic Advisory Group of Experts on Immunization (SAGE) previously issued guidelines for
implementation of the vaccine based on local transmission intensity, recommending countries
consider introducing the vaccine according to seroprevalence thresholds of approximately
70% or greater in the age group targeted for vaccination [14]. These age-related serological
thresholds remain important to consider when assessing population-level impacts and the
cost-effectiveness of dengue vaccination strategies [14–16].
Knowledge of sub-national dengue transmission intensity levels can be extremely valuable
to policy makers when considering the geographic regions and population age-groups that
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may benefit most from prevention and control interventions. Only one nationwide, age-strati-
fied dengue seroprevalence survey has been conducted in Indonesia, in the 2014 urban paedi-
atric population, the results of which are reported by Prayitno et al. [17]. In this paper, we use
the geographically-stratified design of this survey to describe the variation in dengue seroprev-
alence and force of infection across Indonesia, with a view to inform public health policy deci-
sions surrounding dengue vaccination and other prevention strategies.
Methods
Ethics statement
Ethical approval for the original survey was obtained from the Health Research Ethics Com-
mittee of Faculty of Medicine of University of Indonesia. Signed, informed consent was
obtained from a parent or legal guardian of each child for participation in the study as well as
from participants aged 13–18 years. In addition, signed assent was obtained from participants
aged 8–12 years old. Additional approval for this secondary analysis was obtained from the
Ethical Review Committee of the London School of Hygiene and Tropical Medicine.
Seroprevalence survey
A cross-sectional seroprevalence survey, nationally-representative of the urban population,
was carried out between 30th October and 27th November 2014. The cluster sampling design
was self-weighted and adapted from the WHO Expanded Program on Immunization (EPI)
cluster survey method [18]. The survey design and characteristics of the survey population
have been described in detail by Prayitno et al. [17]. Briefly, 30 urban sub-districts in Indonesia
were randomly selected for the study based on probability proportional to population size.
Only sub-districts with a minimum population of 1000 were included in the sampling list to
ensure the desired sample size was obtained. Within each sub-district, 107 healthy children
aged 1–18 years old were enrolled, stratified by age-group. The study aimed to enrol 660 chil-
dren aged 1–4 years (22 per cluster), 870 aged 5–9 years (29 per cluster), 870 aged 10–14 years
(29 per cluster) and 810 aged 15–18 years (27 per cluster), giving a total sample size of 3,210
children. Children were included in the study if they were aged 1–18 years on the day of enrol-
ment, were reported as healthy by a parent or legal guardian, and had been resident in the
selected study site for more than one year. Children were excluded if they had fever (axillary
temperature�37.5˚C) at the time of recruitment or on the day of blood sampling, if any other
child from the household was already included in the study, or if they were unable to report to
the local puskesmas (health centre) for blood drawing within 7 days of the household visit.
Laboratory analysis
Each 2ml sample of venous blood was centrifuged, aliquoted and the serum frozen and stored
at -20˚C. All samples were transported to and processed at the Eijkman Institute for Molecular
Biology in Jakarta, Indonesia. The dengue sero-status of each sample was determined using
the commercial Panbio Dengue IgG enzyme-linked immunosorbent assay (ELISA) as per the
manufacturer’s instructions (Panbio units <9 is negative; 9–11 is equivocal; and >11 is posi-
tive) [17].
Data analysis
Force of infection. A catalytic model was used to estimate the national average force of
infection, λ, assuming an age-independent seroconversion rate. This force of infection (FOI),
λ, is the predicted rate at which individuals of age a move from a seronegative to a seropositive
Dengue in Indonesia
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state, thereby giving an average rate of seroconversion per year of life [19]. The catalytic model
predicts the proportion of children seropositive by age a, pa, using the following equation:
pa ¼ 1   e
  la
We fitted an age-constant model to the serological data using a binomial regression model
with a complementary log-log link as follows:
lnð  lnð1   paÞÞ ¼ lnðlÞ þ lnðaÞ
The constant term in this model, ln(λ), is the natural logarithm of the force of infection.
The natural logarithm of age (the midpoint of each age category in years) is included as an off-
set, with its coefficient constrained to 1. We used the model to estimate a nationally represen-
tative FOI and associated 95% confidence intervals (95% CI), using robust standard errors to
adjust for data dependency within survey clusters. We also estimated cluster-specific FOI.
Based on these estimates, we calculated the proportion of clusters that reached a seropreva-
lence of 50%, 70% and 90% at each year of age.
Additionally, we investigated age-varying models that relaxed the assumption of a fixed
seroconversion rate at all ages using linear piece-wise constants. The Wald test was used to
compare model fit.
Individual and cluster-level determinants of dengue seropositivity. For each sub-dis-
trict, information was obtained on the latitudinal and longitudinal coordinates of the approxi-
mate geographic centroid, as well as the population density as reported in the 2010 Indonesian
census [20]. Region-level data were also obtained from the World Bank Indonesia Database
for Policy and Economic Research on the proportion of households with safe water access, the
household per capita expenditure (in IDR), the proportion of households with access to safe
sanitation, the human development index (HDI) and the immunization coverage of children
under five years [21]. These were all based on 2013 statistics, except for the human develop-
ment index which was only available for 2010. We also used information on the region admin-
istrative status (City or Regency). This classification is based on demography, size and
economy, with City status usually defined by having non-agricultural economic activities [22].
We used generalized estimating equation (GEE) models to investigate associations between
dengue seropositivity and individual- and cluster-level variables [23]. The outcome variable
for this analysis was individual dengue IgG antibody seropositivity. The model formulation
was as follows:
logit PðYij ¼ 1jXijÞ ¼ aþ b1X1ij þ b2X2ij þ � � � þ bkXkij
where P(Yij = 1) represents the probability that an individual j in survey cluster i is seroposi-
tive, X1ij to Xkij represent values of 1 to k independent variables for individual j in survey clus-
ter i, and β1 to βk are the corresponding regression coefficients representing population-
averaged effects. We included as individual-level regressors age, sex and self-reported number
of dengue cases in the household since the participant’s birth, as identified in the original
paper by Prayitno et al. Age (in years) was fitted as a continuous, quadratic variable to allow
for deviations from linearity. We also investigated potential associations between seropositivity
and the above-mentioned district and sub-district level variables. Population density was fitted
as a continuous variable on the logarithmic (base 10) scale, as initial analysis indicated that this
provided a better fit to the data. The proportion of households with safe water access and
household per capita expenditure were grouped into quintiles. We constructed a multivariable,
population-averaged effects model using a forward stepwise approach, including variables in
the model one at a time and assessing their effect on the outcome using odds ratios (OR) and
Dengue in Indonesia
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95% confidence intervals (95% CI) derived from robust standard errors, as well as Wald test p-
values. We evaluated model fit using the Quasilikelihood Information Criterion (QIC), favour-
ing models with a lower value of QIC [24]. We verified that the model was not sensitive to the
model building procedure by repeating the analysis using a backward stepwise variable selec-
tion procedure. All analyses were conducted in Stata 14.0 (Stata Corporation).
Results
A total of 3,194 children were enrolled in the survey, of whom 2,216 (69%, 95% CI: 65–74%)
tested positive for dengue IgG antibodies. Seroprevalence ranged from 26.5% (95% CI: 17.2–
38.4%) amongst one year-olds to 95.3% (95% CI: 85.7–98.6%) amongst 18 year-olds. Assuming
an age-constant FOI, we estimated that 14.0% (95% CI: 11.8–16.6%) of seronegative children
in Indonesia experience their first infection each year, shown in Fig 1. Models allowing for
age-varying forces of infection did not provide a better fit to the data than the age-constant
model.
There was substantial variation in seroprevalence between clusters, ranging from 34.6% to
87.9%. Fig 2 shows the variation between clusters in the predicted FOI, ranging from 4.3%
Fig 1. Observed (orange markers) and model-predicted (blue line) seroprevalence by year of age, based on an overall estimated force of infection, λ, of
14.0% per annum, with corresponding 95% confidence intervals, among children aged 1 to 18 years in Indonesia, 2014.
https://doi.org/10.1371/journal.pntd.0006932.g001
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(95% CI: 3.1–6.0%) per year in cluster 22, to 30.0% (95% CI: 22.4–40.2%) per year in cluster
30, see S1 Table for full details. The relationship between force of infection estimates and the
observed and predicted total seroprevalence amongst 1–18 year olds is shown in Fig 3, where
predicted seroprevalence is calculated assuming an age-constant force of infection and a uni-
form age-distribution.
Fig 4 shows the percentage of sub-districts that reach a seroprevalence of 50%, 70% and
90% by year of age, based on the predicted force of infection estimates. Our models show that
by age nine 87% (26/30), 60% (18/30) and 10% (3/30) of sub-districts will have reached a sero-
prevalence level�50%,�70% and�90%, respectively. By age eleven 97% (29/30), 83% (25/30)
and 20% (6/30) have respectively reached these levels of seroprevalence.
Initial assessment of correlations between independent variables indicated a strong correla-
tion between district-level household per capita expenditure and the proportion of households
with access to safe water (Spearman’s rho = 0.77), and only the former was included in multi-
variable analyses. Human Development Index, immunization coverage and geographic coor-
dinates showed no association with dengue seropositivity and were not included in
multivariable analysis. In the final multivariable GEE model controlling for age, sex and the
self-reported number of dengue cases in the household since the participant’s birth, cluster-
level variables associated with dengue seropositivity included district-level administrative
Fig 2. Estimated cluster-specific annual forces of infection with associated 95% confidence intervals among children aged 1 to 18 years in Indonesia, 2014.
https://doi.org/10.1371/journal.pntd.0006932.g002
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status, household per capita expenditure, and sub-district level population density (Table 1).
The odds of seropositivity were 92% higher among individuals residing in districts with City as
opposed Regency administrative status (OR = 1.92, 95% CI: 1.32–2.80), and increased by 54%
on average per 10-fold increase in population density (OR = 1.54, 95% CI: 1.03–1.71) between
the range of 241–38,182 inhabitants per km2. The backward stepwise variable selection proce-
dure yielded the same final model.
Discussion
To our knowledge, this is the first detailed analysis of within-country variation in dengue sero-
prevalence and force of transmission. Financial and logistical challenges in conducting large-
scale, geographically widespread serological studies mean that such surveys are often restricted
to a very limited number of sites. Our data, from a cluster-sample survey representative of
urban areas in Indonesia, provided a unique opportunity to study geographic variation in den-
gue transmission. Our results indicate a high dengue transmission intensity in the paediatric
population of Indonesia, with 14.0% seroconverting per year, similar to estimates found in
Fig 3. Observed (orange markers) and model-predicted (blue line) cluster-specific seroprevalence against estimated cluster-specific force of infection among
children aged 1 to 18 years in Indonesia, 2014.
https://doi.org/10.1371/journal.pntd.0006932.g003
Dengue in Indonesia
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Colombo, Sri Lanka (14.1%) in children aged 0–12 years [14]. The survey was not designed to
estimate force of infection at sub-national level and further work, for example supplementing
seroprevalence information with sub-national dengue notification data, could help to deter-
mine how representative the estimates are of different administrative levels. However, our
analyses highlight the highly heterogeneous nature of dengue transmission in Indonesia, with
sub-district seroprevalence ranging from 35% to 88%. These findings are relevant for inform-
ing dengue vaccination strategies, as they highlight the within-country variation in force of
infection and therefore the variability in the expected proportion of seropositive individuals in
any one age group targeted for vaccination. Importantly, based on the predicted FOI estimates,
60% of clusters reached a seroprevalence of�70% by age nine years, rising to 83% of clusters
by age 11 years.
We found higher population density and City status to be associated with elevated odds of
dengue seropositivity. This is not surprising given the epidemiology of dengue virus, which is
primarily transmitted by the mainly urban Aedes aegypti mosquito. Higher population density
is likely to be an indicator of increasing urbanization and higher transmission risk.
A number of limitations should be considered when interpreting our analysis. The original
survey was designed to be nationally representative rather than provide estimates of
Fig 4. Proportion of clusters expected to reach seroprevalence levels of 50%, 70% and 90% by year of age, based on models with an age-constant force of
infection.
https://doi.org/10.1371/journal.pntd.0006932.g004
Dengue in Indonesia
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seroprevalence by geographic region. Consequently, the sample size in each cluster was modest
and the self-weighted survey design meant that clusters were sampled favourably from areas
with higher population size. As a result, more sparsely populated areas were under-represented
in our analysis. The survey was also confined to urban areas. Nevertheless, the availability of
data from 30 locations presented a unique opportunity to investigate geographic variation in
dengue transmission.
We assumed a constant force of infection over time in our analyses. Whilst our age-varying
model for the total study population showed no evidence of variation in FOI by age, past epi-
demics could have resulted in specific age groups having disproportionately high seroconver-
sion rates, potentially inflating force of infection estimates, particularly when analysing
cluster-specific data. However, this is unlikely to explain our observation that certain clusters
had considerably lower seroprevalence and force of infection than others.
The clustered, age-stratified sampling design enabled assessment of the relationship
between cluster-level seroprevalence and force of infection in 1–18 year olds. Our catalytic
models estimating cluster-level force of infection fit the data well and could largely reproduce
the total seroprevalence in individual clusters assuming a uniform age-distribution (Fig 3). As
the sampling strategy of individual clusters was approximately evenly distributed by age-group
Table 1. Factors associated with dengue seropositivity in children aged 1–18 years, results from multivariable population-averaged effects model, Indonesia 2014.
95% CI
Variable OR Lower Upper p4
Age1
Linear age term 1.53 1.37 1.71 <0.001
Squared age term 0.99 0.98 0.99
Sex
Female 1.00 — — 0.048
Male 0.86 0.74 1.00
Population density2
Per 10-fold increase 1.54 1.03 1.71 0.037
Household per capita expenditure
1st quintile 1.00 — — <0.001
2nd quintile 1.64 0.76 3.54
3rd quintile 2.79 1.25 6.23
4th quintile 1.39 0.65 2.95
5th quintile 0.77 0.37 1.59
Administrative status
Regency 1.00 — — 0.006
City 1.92 1.32 2.80
Household dengue cases3
0 1.00 — — <0.001
1 2.38 1.62 3.50
>1 3.78 1.28 11.14
Don't know 1.28 0.93 1.74
No data 1.07 0.56 2.06
1Age modelled as a continuous, quadratic term
2Population density modelled on logarithmic (base 10) scale, the minimum and maximum values were 241 and 38,182 inhabitants per km2
3Self-reported dengue cases in household since participant’s birth
4Wald test p-value
https://doi.org/10.1371/journal.pntd.0006932.t001
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(21% 1–4, 27% 5–9, 27% 10–14, and 25% 15–19) we expect these results to be largely generaliz-
able to similarly age-stratified surveys in paediatric populations. Force of infection estimates
from age-constant catalytic models are invaluable for estimating the long-term average infec-
tion rates required for assessment of vaccine suitability.
In our survey, dengue seropositivity was determined using a commercial IgG ELISA. IgG
seropositivity measures past exposure to at least one dengue serotype, but provides no infor-
mation about exposure to individual serotypes, precluding estimation of serotype-specific
forces of infection. However, force of infection estimates from IgG seroprevalence data have
been shown to be comparable to the sum of serotype-specific forces of infection derived from
plaque reduction neutralization tests (PRNT) [25]. A further complication of IgG ELISA
results is the possibility of cross-reactivity with antibodies against other flaviviruses, including
those raised following vaccination against Japanese encephalitis and yellow fever viruses. Pre-
vious studies in US travellers have shown high levels of false positive results when using manu-
facturer recommended diagnostic thresholds, suggesting a need to optimise cut-offs by
validating ELISA tests against PRNT results [26]. We expect this to be much less of a problem
in Indonesia, where dengue virus is the predominant circulating flavivirus and where there
was no Japanese encephalitis immunization programme at the time of the survey [27,28].
Indeed, PRNTs in a third of IgG positive samples from our survey indicated that 98% were
positive for at least one dengue serotype [29].
Our analysis of geographic determinants of seroprevalence was limited by the availability of
data with adequate geographic resolution. Data on drinking water infrastructure, vector densi-
ties and weather factors were not available at the sub-district level and therefore not accounted
for in this analysis. Further research to establish the role of climate and other determinants in
dengue transmission across Indonesia could help to predict areas or periods of high dengue
transmission intensity, in order to effectively target control measures or further characterize
geographic regions that could benefit from a dengue vaccination campaign.
This study highlights the value of geographically-stratified dengue seroprevalence data to
understand the variation in dengue epidemiology, and inform prevention and control strate-
gies, including dengue vaccination. Our study describes the variability in dengue endemicity
which is observed between individual sub-districts within urban areas of a dengue-endemic
country. Largely urbanized areas with high population densities may be where implementation
of dengue control and prevention strategies would be of most value.
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